Esposito Cecilia Maria, Barkin Jennifer L, Ceresa Alessandro, Nosari Guido, Di Paolo Martina, Legnani Francesca, Cirella Luisa, Surace Teresa, Tagliabue Ilaria, Capuzzi Enrico, Caldiroli Alice, Dakanalis Antonios, Politi Pierluigi, Clerici Massimo, Buoli Massimiliano
Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.
J Clin Med. 2023 Sep 11;12(18):5902. doi: 10.3390/jcm12185902.
Psychotic symptoms occur in more than half of patients affected by Bipolar Disorder (BD) and are associated with an unfavorable course of the disorder. The objective of this study is to identify the differences in the clinical and biochemical parameters between bipolar patients with or without psychotic symptoms.
A total of 665 inpatients were recruited. Demographic, clinical, and biochemical data related to the first day of hospitalization were obtained via a screening of the clinical charts and intranet hospital applications. The two groups identified via the lifetime presence of psychotic symptoms were compared using t tests for quantitative variables and χ tests for qualitative ones; binary logistic regression models were subsequently performed.
Patients with psychotic BD (compared to non-psychotic ones) showed a longer duration of hospitalization ( < 0.001), higher Young Mania Rating Scale scores ( < 0.001), lower Global Assessment of Functioning scores ( = 0.002), a less frequent history of lifetime suicide attempts ( = 0.019), less achievement of remission during the current hospitalization ( = 0.028), and a higher Neutrophile to Lymphocyte Ratio (NLR) ( = 0.006), but lower total cholesterol ( = 0.018) and triglycerides ( = 0.013).
Patients with psychotic BD have a different clinical and biochemical profile compared to their counterparts, characterized by more clinical severity, fewer metabolic alterations, and a higher grade of inflammation. Further multi-center studies have to confirm the results of this present study.
超过半数的双相情感障碍(BD)患者会出现精神病性症状,且这些症状与该疾病的不良病程相关。本研究的目的是确定有或无精神病性症状的双相情感障碍患者在临床和生化参数上的差异。
共招募了665名住院患者。通过筛查临床病历和医院内部网络应用程序,获取与住院第一天相关的人口统计学、临床和生化数据。对通过终生存在精神病性症状确定的两组患者,定量变量采用t检验,定性变量采用χ检验进行比较;随后进行二元逻辑回归模型分析。
有精神病性症状的双相情感障碍患者(与无精神病性症状的患者相比)住院时间更长(<0.001),杨氏躁狂评定量表得分更高(<0.001),功能总体评定得分更低(=0.002),终生自杀未遂史的发生率更低(=0.019),本次住院期间缓解的达成率更低(=0.028),中性粒细胞与淋巴细胞比值(NLR)更高(=0.006),但总胆固醇(=0.018)和甘油三酯更低(=0.013)。
有精神病性症状的双相情感障碍患者与其无精神病性症状的 counterparts相比,具有不同的临床和生化特征,其特点是临床严重程度更高、代谢改变更少以及炎症程度更高。进一步的多中心研究必须证实本研究的结果。